CRISPR Therapeutics (CRSP) logo

CRSP earnings date, and what happened the last 4 times

Next report

Mon Nov 9

Quality Score today -7

After the close, in 14 days. Expected: the company has not confirmed it.

CRSP closed higher after 2 of its last 4 reports. On average it closed +3.1% the session after a report.

The moment CRSP reports

  • Its figures, in plain words
  • How it moves after, beside its last four
  • Its Quality Score going in, and after
Get an alert when CRSP reports, with its figures

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

What happened after CRSP's last 4 reports

CRSP's last 4 earnings reports
ReportedScore
going in
GapReaction
Aug 3, 20262026 · After close-3estimated+2.0%+7.1%
May 4, 20262026 · After close-3estimated-1.8%-2.2%
Feb 12, 20262026 · After close-4estimated+1.7%+8.5%
Nov 10, 20252025 · Before open3estimated+5.3%-1.0%
  • Aug 3, 2026, after the close: the next session CRSP opened +2.0% and closed +7.1%, and five sessions on it stood +8.0%. Its Quality Score going in was -3 (Poor), estimated.
  • May 4, 2026, after the close: the next session CRSP opened -1.8% and closed -2.2%, and five sessions on it stood +0.8%. Its Quality Score going in was -3 (Poor), estimated.
  • Feb 12, 2026, after the close: the next session CRSP opened +1.7% and closed +8.5%, and five sessions on it stood +9.3%. Its Quality Score going in was -4 (Poor), estimated.
  • Nov 10, 2025, before the open: that session CRSP opened +5.3% and closed -1.0%, and five sessions on it stood -4.7%. Its Quality Score going in was 3 (Below Average), estimated.

Across these 4 reports CRSP opened higher after 3 of 4 and closed higher after 2 of 4; on average it opened +1.8%, closed +3.1%, and stood +3.3% five sessions on. Its Quality Score is -7 today, against -3 going into its Aug 3, 2026 report.

Gap: where the stock opened the session after the report. Reaction: where that session closed. Both against the close before the report. The largest of the 4: +8.5% after the Feb 12, 2026 report. A score marked estimated was worked out afterwards from that day's prices and filings; Breakaway has recorded every score live since Sep 9 2026.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Pro members see CRSP's reaction live as a report comes out, the release's figures, and an optional alert before it reports.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Questions about CRSP's earnings

As of Oct 26, 2026: CRISPR Therapeutics (CRSP): expected to report Mon Nov 9, after the close. CRSP closed higher after 2 of its last 4 reports. Its Quality Score is -7 (Poor). Scores as of 11:11 PM ET, 15 minutes behind.

When is CRSP's next earnings date?

Expected to report Mon Nov 9, after the close, a date Breakaway expects from the company's usual timing; the company has not confirmed it. CRSP closed higher after 2 of its last 4 reports. Past behavior, not a forecast.

Does CRSP report before or after the market?

CRSP is expected to report Mon Nov 9, after the close. Its last 4 reports came 3 after the close and 1 before the open.

How did CRSP stock react to its last earnings report?

Aug 3, 2026, after the close: the next session CRSP opened +2.0% and closed +7.1%, and five sessions on it stood +8.0%.

Does CRSP stock usually go up after earnings?

CRSP closed higher after 2 of its last 4 reports. On average it closed +3.1% the session after a report, after opening +1.8%. Past behavior, not a forecast.

CRISPR Therapeutics' page has its Quality Score, its chart, and its insiders' trades. Who reports this week: the earnings calendar.

Past behavior, not a forecast. The score is delayed at least 15 minutes; the reports' moves are as they closed.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs; recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.